Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment

被引:135
作者
Sahiratmadja, Edhyana
Alisjahbana, Bachti
de Boer, Tjitske
Adnan, Iskandar
Maya, Anugrah
Danusantoso, Halim
Danusantoso, Ronald
Nelwan, Ronald H. H.
Marzuki, Sangkot
van der Meer, Jos W. M.
van Crevel, Reinout
van de Vosse, Esther
Ottenhoff, Tom H. M.
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2333 ZA Leiden, Netherlands
[3] Eijkman Inst Mol Biol, Jakarta, Indonesia
[4] Univ Padjadjaran, Fac Med, Dept Internal Med, Div Trop & Infect Dis, Bandung, Indonesia
[5] Indonesian TB Control Assoc PPTI, Jakarta, Indonesia
[6] Univ Indonesia, Fac Med, Dept Internal Med, Div Trop & Infect Dis, Jakarta, Indonesia
[7] Univ Nijmegen, Radboud Med Ctr, Dept Internal Med, Nijmegen, Netherlands
关键词
D O I
10.1128/IAI.00602-06
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pro- and anti-inflammatory cytokines and their signaling pathways play key roles in protection from and pathogenesis of mycobacterial infection, and their balance and dynamic changes may control or predict clinical outcome. Peripheral blood cells' capacity to produce proinflammatory (tumor necrosis factor alpha [TNF-alpha], interleukin-12/23p40 [IL-12/23p40], and gamma interferon [IFN-gamma]) and anti-inflammatory (IL-10) cytokines in response to Mycobacterium tuberculosis or unrelated stimuli (lipopolysaccharide, phytohernagglutinin) was studied in 93 pulmonary tuberculosis (TB) patients and 127 healthy controls from Indonesia. Their cells' ability to respond to IFN-gamma was examined to investigate whether M. tuberculosis infection can also inhibit IFN-gamma receptor (IFN-gamma R) signaling. Although there was interindividual variability in the observed responses, the overall results revealed that M. tuberculosis-induced TNF-alpha and IFN-gamma levels showed opposite trends. Whereas TNF-alpha production was higher in active-TB patients than in controls, IFN-gamma production was strongly depressed during active TB, correlated inversely with TB disease severity, and increased during therapy. By contrast, mitogen-induced IFN-gamma production, although lower in patients than in controls, did not change during treatment, suggesting an M. tuberculosis-specific and reversible component in the depression of IFN-gamma. Depressed IFN-gamma production was not due to decreased IL-12/IL-23 production. Importantly, IFN-gamma-inducible responses were also significantly depressed during active TB and normalized during treatment, revealing disease activity-related and reversible impairment in IFN-gamma R signaling in TB. Finally, IFN-gamma/IL-10 ratios significantly correlated with TB cure. Taken together, these results show that M. tuberculosis-specific stimulation of IFN-gamma (but not TNF-alpha) production and IFN-gamma R signaling are significantly depressed in active TB, correlate with TB disease severity and activity, and normalize during microbiological TB cure. The depression of both IFN-gamma production and IFN-gamma R signaling may synergize in contributing to defective host control in active TB.
引用
收藏
页码:820 / 829
页数:10
相关论文
共 60 条
[1]  
Alisjahbana B, 2006, INT J TUBERC LUNG D, V10, P696
[2]   Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection [J].
Altare, F ;
Lammas, D ;
Revy, P ;
Jouanguy, E ;
Döffinger, R ;
Lamhamedi, S ;
Drysdale, P ;
Scheel-Toellner, D ;
Girdlestone, J ;
Darbyshire, P ;
Wadhwa, M ;
Dockrell, H ;
Salmon, M ;
Fischer, A ;
Durandy, A ;
Casanova, JL ;
Kumararatne, DS .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (12) :2035-2040
[3]   Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency [J].
Altare, F ;
Durandy, A ;
Lammas, D ;
Emile, JF ;
Lamhamedi, S ;
Le Deist, F ;
Drysdale, P ;
Jouanguy, E ;
Döffinger, R ;
Bernaudin, F ;
Jeppsson, O ;
Gollob, JA ;
Meinl, E ;
Segal, AW ;
Fischer, A ;
Kumararatne, D ;
Casanova, JL .
SCIENCE, 1998, 280 (5368) :1432-1435
[4]  
[Anonymous], DIAGNOSTIC STANDARDS
[5]   T cell immune responses to mycobacterial antigens in Brazilian tuberculosis patients and controls [J].
Antas, PRZ ;
Cardoso, FLL ;
Pereira, KC ;
Franken, KLMC ;
Cunha, KS ;
Klatser, P ;
Sarno, EN ;
Ottenhoff, THM ;
Sampaio, EP .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2005, 99 (09) :699-707
[6]  
Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936
[7]  
BARNES PF, 1989, J IMMUNOL, V142, P1114
[8]   CYTOKINE PRODUCTION AT THE SITE OF DISEASE IN HUMAN TUBERCULOSIS [J].
BARNES, PF ;
LU, SZ ;
ABRAMS, JS ;
WANG, E ;
YAMAMURA, M ;
MODLIN, RL .
INFECTION AND IMMUNITY, 1993, 61 (08) :3482-3489
[9]   Natural regulatory T cells in infectious disease [J].
Belkaid, Y ;
Rouse, BT .
NATURE IMMUNOLOGY, 2005, 6 (04) :353-360
[10]   BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies [J].
Black, GF ;
Weir, RE ;
Floyd, S ;
Bliss, L ;
Warndorff, DK ;
Crampin, AC ;
Ngwira, B ;
Sichali, L ;
Nazareth, B ;
Blackwell, JM ;
Branson, K ;
Chaguluka, SD ;
Donovan, L ;
Jarman, E ;
King, E ;
Fine, PEM ;
Dockrell, HM .
LANCET, 2002, 359 (9315) :1393-1401